Pharmacists in Norristown, PA Accepting Medicare
66 Pharmacists found. Showing 61 - 66
 Dr. Cristina Fersini Miller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2550 Eisenhower Ave Bldg B, Norristown, PA 19403 Phone: 484-690-0160 |
 Elek Lefkoe Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 328 Dekalb St, Norristown, PA 19401 Phone: 610-272-0637 Fax: 610-272-1373 |
Dr. Michael Bartholomew Lacon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1336 Powell St, Norristown, PA 19401 Phone: 610-279-0140 Fax: 610-279-5767 |
Alpa Sherman Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 699 W Germantown Pike, Norristown, PA 19403 Phone: 610-630-5819 |
Susan Lacon, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 Sterigere St Bldg 10, Norristown, PA 19401 Phone: 610-313-5995 |
Amanda Kim Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3300 Dekalb Pike, Norristown, PA 19401 Phone: 610-930-0054 |
News Archive
Workplace wellness programs: Good for health costs?
Some companies offer discounts to healthy employees, but patient advocates fear such wellness programs could be unfair.
Electronic medical records may help doctors spot or predict abuse
As the data stored in electronic medical records grow, the technology may be able to help doctors predict domestic abuse and other medical conditions, a new study in the British Medical Journal finds, Reuters reports. Patients with injuries, poisoning and alcoholism were more likely than others to report domestic abuse.
Strathspey Crown Holdings announces acquisition of Novus Via assets
Strathspey Crown Holdings LLC announced today the acquisition of the portfolio companies of Novus Via LP, a Nevada-based venture capital investment firm focused on end-stage development and commercialization of advanced electromagnetic and electrochemical technologies spanning healthcare, clean energy and coherent acoustics. The terms of the transaction were not disclosed.
FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial
Arisaph Pharmaceuticals, Inc., a privately held drug discovery biopharmaceutical company, today announced that the U.S. Food and Drug Administration has accepted the Company's recently submitted Investigational New Drug application to evaluate ARI-3037MO in a phase I human clinical trial in healthy volunteers.
New guidelines for evaluation and treatment of perimenopausal depression
It is well-recognized that women are at increased risk of depression during postpartum when hormone levels are changing, but the risk of depression associated with perimenopause - the time right before menopause when female hormones are in decline - remains under-recognized and clinical recommendations on how to diagnose and treat this kind of depression in women have been lacking until now.
› Verified 9 days ago
Pharmacists
Counselors
Dentists
Occupational Therapists
Psychologists
Clinical Social Workers